| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in AXSM over the last quarter tilts toward selling: insiders offloaded a net 59,664 shares worth roughly $12.6M.
Classified under Biotechnology (Health Care sector), AXSM's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 105.0K | - | - | |
| CFO | 75.9K | $265.5K | - | |
| Dir | 58.4K | $14.54M | - | |
| Dir | 30.4K | $7.57M | - | |
| Other | 23.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | Maizel Ari | Chief Commercial Officer | Sale+OE | 7,500 | $182.42 | $1,368,150.00 | -100% | +27.1% | - | |
| Feb 26, 2026 | Coleman Mark | Director | Sell | 25,000 | $161.11 | $4,027,750.00 | -34.7% | +43.7% | - | |
| Feb 26, 2026 | Jacobson Mark L. | Chief Operating Officer | Sale+OE | 35,378 | $161.88 | $5,726,990.64 | -100% | +43.7% | - | |
| Feb 2, 2026 | Tabuteau Herriot45 | Chief Executive Officer | Sale+OE | 32,410 | $185.60 | $6,015,296.00 | -81.8% | +20.3% | - | |
| Jan 22, 2026 | Pizzie Nick50 | Chief Financial Officer | Sale+OE | 12,000 | $187.92 | $2,255,040.00 | -22.0% | -0.3% | - | |
| Jan 21, 2026 | Maizel Ari | Chief Commercial Officer | Sale+OE | 7,500 | $184.44 | $1,383,300.00 | -100% | -3.2% | - | |
| Jan 7, 2026 | Tabuteau Herriot45 | Chief Executive Officer | Sale+OE | 139,414 | $171.30 | $23,881,617.52 | -95.1% | -1.1% | - | |
| Dec 31, 2025 | Saad Mark E50 | Director | Sale+OE | 37,577 | $165.18 | $6,206,968.86 | -79.0% | -7.5% | - | |
| Dec 4, 2025 | Tabuteau Herriot45 | Chief Executive Officer | Sale+OE | 79,973 | $145.66 | $11,648,582.34 | -91.7% | +10.8% | - | |
| Nov 5, 2025 | Tabuteau Herriot45 | Chief Executive Officer | Sale+OE | 163,939 | $133.07 | $21,815,669.06 | -95.8% | +38.1% | - |